From crisis to opportunity: A perspective on the heparin crisisSASISEKHARAN, Ram; SHRIVER, Zachary.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 854-858, issn 0340-6245, 5 p.Conference Paper

Complex sugars as emerging therapeutic targetsPOJASEK, Kevin; SASISEKHARAN, Ram.International sugar journal. 2002, Vol 104, Num 1243, pp 306-312, issn 0020-8841, 7 p.Article

Multifunctional Nanoscale Platforms for Targeting of the Cancer Cell Immortality SpectrumSOUNDARARAJAN, Venkataramanan; WARNOCK, Kenneth; SASISEKHARAN, Ram et al.Macromolecular rapid communications. 2010, Vol 31, Num 2, pp 202-216, issn 1022-1336, 15 p.Article

Competitive Inhibition of Heparinase by Persulfonated Glycosaminoglycans: A Tool to Detect Heparin ContaminationAICH, Udayanath; SHRIVER, Zachary; THARAKARAMAN, Kannan et al.Analytical chemistry (Washington). 2011, Vol 83, Num 20, pp 7815-7822, issn 0003-2700, 8 p.Article

Nitric oxide modulates hepatocyte growth factor/scatter factor-induced angiogenesisSENGUPTA, Shiladitya; SELLERS, Lynda A; GHERARDI, Ermanno et al.Angiogenesis (London). 2004, Vol 7, Num 4, pp 285-294, issn 0969-6970, 10 p.Article

The Tainted Heparin Story: An UpdateGUERRINI, Marco; SHRIVER, Zachary; BISIO, Antonella et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 907-911, issn 0340-6245, 5 p.Conference Paper

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery systemSENGUPTA, Shiladitya; EAVARONE, David; CAPILA, Ishan et al.Nature (London). 2005, Vol 436, Num 7050, pp 568-572, issn 0028-0836, 5 p.Article

Low molecular weight heparins : Structural differentiation by bidimensional nuclear magnetic resonance spectroscopyGUERRINI, Marco; GUGLIERI, Sara; NAGGI, Annamaria et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 478-487, issn 0094-6176, 10 p.Conference Paper

Heparin and Heparan Sulfate: Analyzing Structure and MicroheterogeneitySHRIVER, Zachary; CAPILA, Ishan; VENKATARAMAN, Ganesh et al.Handbook of experimental pharmacology. 2012, Vol 207, pp 159-176, issn 0171-2004, 18 p.Article

M 118-A rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromesKEI KISHIMOTO, Takashi; YI WEI QI; LONG, Alison et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 900-906, issn 0340-6245, 7 p.Conference Paper

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsGUERRINI, Marco; BECCATI, Daniela; AL-HAKIM, Ali et al.Nature biotechnology (Print). 2008, Vol 26, Num 6, pp 669-675, issn 1087-0156, 7 p.Article

Outbreak of Adverse Reactions Associated with Contaminated HeparinBLOSSOM, David B; KALLEN, Alexanderj; JONES, Marilyn et al.The New England journal of medicine. 2008, Vol 359, Num 25, pp 2674-2684, issn 0028-4793, 11 p.Article

Targeting of mitogen-activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesisSENGUPTA, Shiladitya; SELLERS, Lynda A; LI, Rung-Chi et al.Circulation (New York, N.Y.). 2003, Vol 107, Num 23, pp 2955-2961, issn 0009-7322, 7 p.Article

Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesisSENGUPTA, Shiladitya; SELLERS, Lynda A; CINDROVA, Tereza et al.Cancer research (Baltimore). 2003, Vol 63, Num 23, pp 8351-8359, issn 0008-5472, 9 p.Article

Small Molecule Targeting Malaria Merozoite Surface Protein-1 (MSP-1) Prevents Host Invasion of Divergent Plasmodial SpeciesCHANDRAMOHANADAS, Rajesh; BASAPPA; NOSTEN, Francois et al.The Journal of infectious diseases. 2014, Vol 210, Num 10, pp 1616-1626, issn 0022-1899, 11 p.Article

Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic DriftHENSLEY, Scott E; DAS, Suman R; YEWDELL, Jonathan W et al.Science (Washington, D.C.). 2009, Vol 326, Num 5953, pp 734-736, issn 0036-8075, 3 p.Article

Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and MiceMAINES, Taronna R; JAYARAMAN, Akita; ROMAN, Rahul et al.Science (Washington, D.C.). 2009, Vol 325, Num 5939, pp 484-487, issn 0036-8075, 4 p.Article

Structural features of low-molecular-weight heparins affecting their affinity to antithrombinBISIO, Antonella; VECCHIETTI, Davide; CITTERIO, Laura et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 865-873, issn 0340-6245, 9 p.Conference Paper

Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factorSENGUPTA, Shiladitya; GHERARDI, Ermanno; SELLERS, Lynda A et al.Arteriosclerosis, thrombosis, and vascular biology. 2003, Vol 23, Num 1, pp 69-75, issn 1079-5642, 7 p.Article

Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycansDONGFANG LIU; SHRIVER, Zachary; YIWEI QI et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 1, pp 67-78, issn 0094-6176Article

Glycome and Transcriptome Regulation of VasculogenesisHARFOUCHE, Rania; HENTSCHEL, Dirk M; PIECEWICZ, Stephanie et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 19, pp 1883-1892, issn 0009-7322, 10 p.Article

Contaminated heparin associated with adverse clinical events and activation of the contact systemKISHIMOTO, Takashi Kei; VISWANATHAN, Karthik; AL-HAKIM, Ali et al.The New England journal of medicine. 2008, Vol 358, Num 23, pp 2457-2467, issn 0028-4793, 11 p.Article

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapyYANG YANG; MACLEOD, Veronica; VLODAVSKY, Israel et al.Blood. 2007, Vol 110, Num 6, pp 2041-2048, issn 0006-4971, 8 p.Article